ScreenerHero

APLI Appili Therapeutics Inc.

TSX · CA · Healthcare · Biotechnology · appilitherapeutics.com
0.0100CAD0.00%Mkt Cap: 481985 $P/E: —

Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of treatments targeting unmet needs in infectious diseases in the United States and Canada. The company offers LIKMEZ (ATI…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap481.98K USD
Enterprise Value10.57M USD
Revenue (TTM)263.68K USD
Gross Profit263.68K USD
Net Income (TTM)-3.09M USD
Revenue/Share0.0030 CAD
Last Price0.0100 CAD
Fiscal Year EndMar 2026
MR QuarterJun 2026
Employees7
CountryCA
SectorHealthcare
IndustryBiotechnology
ISINCA03783R1073
Valuation
P/E (Trailing)—
P/E (Forward)-0.13
PEG—
EV/EBITDA-2.22
EV/Revenue40.08
P/S1.83
P/B-0.03
EPS (TTM)-0.04
EPS (Forward)-0.04
52W Range
0.005014% of range0.0400
52W High0.0400 CAD
52W Low0.0050 CAD
Profitability
Gross Margin100.00%
Oper. Margin-1368.87%
EBITDA Margin0.00%
Profit Margin-1736.73%
ROE24.47%
ROA-214.89%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-973.98K USD
CapEx (TTM)—
FCF Margin-700.57%
FCF Yield-383.27%
Net Debt9.60M USD
Net Debt/EBITDA-2.02
Balance Sheet
Debt/Equity-0.75
Current Ratio0.07
Quick Ratio0.06
Book Value/Sh-0.14 CAD
Cash/Share0.0010 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 CAD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.132.37M
Float117.93M
Insiders0.06%
Institutions10.85%
Short Interest
Short Ratio0.6d
Short % Out.0.01%
Shares Short13.80K
Short (prev mo.)9.65K
Technical
SMA 500.0113 (-11.5%)
SMA 2000.0163 (-38.6%)
Beta0.14
S&P 52W Chg16.45%
Avg Vol (30d)70.18K
Avg Vol (10d)138.77K
Technical Indicators
RSI (14)47.4
MACD-0.0008
MACD Signal-0.0006
MACD Hist.-0.0002
BB Upper0.0162 CAD
BB Middle0.0110 CAD
BB Lower0.0058 CAD
BB Width95.12%
ATR (14)0.0024 CAD
Vol Ratio (20d)0.69x